Lieu, Alexander C.
Shoji, Marissa K.
Aakalu, Vinay K.
Liu, Catherine Y.
Article History
Accepted: 5 June 2024
First Online: 5 July 2024
Declarations
: <b>Catherine Y. Liu</b> - Principal Investigator of Lassen-Sponsored clinical trial, past principal investigator of Amgen-Sponsored clinical trial, royalties from Wolters Kluwers Health
: <b>Vinay K. Aakalu</b> -None of the following directly relate to the current manuscript: Patents: University of Illinois; University of Michigan Clinical Trials: Amgen, Sling Therapeutics, Roche.
: Research Funding: National Institutes of Health (NINDS, NEI); Research to Prevent Blindness; Prior Funding: Veterans Affairs Office of Research and Development, Department of Defense, National Science Foundation.
: Equity: 8th Line; ViSo Therapeutics Inc.
: The remaining authors declare that they have no conflict of interest.
: This article does not contain any studies with human or animal subjects performed by any of the authors.
: The authors declare no competing interests.